Total Payments
$28,928
2024 Payments
$1,182
Companies
13
Transactions
37
Medicare Patients
1,400
Medicare Billing
$148,102
Payment Breakdown by Category
Consulting$12,588 (43.5%)
Other$11,400 (39.4%)
Travel$3,516 (12.2%)
Food & Beverage$1,424 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,588 | 4 | 43.5% |
| Honoraria | $7,000 | 2 | 24.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,400 | 2 | 15.2% |
| Travel and Lodging | $3,516 | 10 | 12.2% |
| Food and Beverage | $1,424 | 19 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $8,430 | 9 | $0 (2024) |
| Torax Medical, Inc. | $5,727 | 6 | $0 (2017) |
| Covidien LP | $4,893 | 7 | $0 (2020) |
| Braintree Laboratories, Inc. | $3,300 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $2,269 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,140 | 1 | $0 (2021) |
| Endogastric Solutions, Inc | $1,692 | 3 | $0 (2019) |
| Medtronic, Inc. | $176.23 | 3 | $0 (2024) |
| QOL Medical, LLC | $124.99 | 1 | $0 (2021) |
| NinePoint Medical, Inc. | $63.04 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,182 | 5 | Phathom Pharmaceuticals, Inc. ($1,000) |
| 2023 | $10,730 | 9 | Phathom Pharmaceuticals, Inc. ($7,430) |
| 2022 | $2,319 | 3 | AstraZeneca Pharmaceuticals LP ($2,269) |
| 2021 | $2,265 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($2,140) |
| 2020 | $4,400 | 2 | Covidien LP ($4,400) |
| 2019 | $463.60 | 5 | Covidien LP ($359.05) |
| 2018 | $1,746 | 3 | Endogastric Solutions, Inc ($1,645) |
| 2017 | $5,823 | 8 | Torax Medical, Inc. ($5,727) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | Medtronic, Inc. | BARRX (Device) | Food and Beverage | In-kind items and services | $55.98 | General |
| Category: Ablation | ||||||
| 04/02/2024 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $70.24 | General |
| Category: Motility Testing | ||||||
| 03/15/2024 | PENTAX of America, Inc. | INSPIRA (Device), PENTAX Medical, PENTAX Medical | Food and Beverage | Cash or cash equivalent | $31.11 | General |
| Category: Gastroenterology | ||||||
| 03/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2023 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug), VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK | Honoraria | Cash or cash equivalent | $6,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/08/2023 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $663.26 | General |
| 12/08/2023 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $343.31 | General |
| 12/08/2023 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $245.58 | General |
| 12/08/2023 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 12/08/2023 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 12/08/2023 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 12/08/2023 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $22.48 | General |
| 12/01/2023 | Braintree Laboratories, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 05/29/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Respiratory | ||||||
| 05/20/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $120.51 | General |
| Category: Respiratory | ||||||
| 02/28/2022 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $50.01 | General |
| Category: Motility Testing | ||||||
| 10/27/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 06/29/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/25/2020 | Covidien LP | Bravo (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Reflux Testing | ||||||
| 02/25/2020 | Covidien LP | Emprint (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Ablation | ||||||
| 10/30/2019 | Covidien LP | Bravo (Device) | Food and Beverage | In-kind items and services | $99.97 | General |
| Category: Ablation | ||||||
| 10/15/2019 | Covidien LP | Bravo (Device) | Food and Beverage | In-kind items and services | $145.40 | General |
| Category: Ablation | ||||||
| 09/23/2019 | Covidien LP | — | Travel and Lodging | In-kind items and services | $113.68 | General |
| 08/21/2019 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $47.52 | General |
| Category: GERD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 373 | 398 | $399,215 | $34,325 |
| 2022 | 10 | 352 | 379 | $348,965 | $34,812 |
| 2021 | 11 | 397 | 444 | $369,615 | $48,482 |
| 2020 | 8 | 278 | 319 | $224,925 | $30,482 |
Total Patients
1,400
Total Services
1,540
Medicare Billing
$148,102
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 60 | 60 | $31,500 | $6,724 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 68 | 77 | $32,725 | $6,256 | 19.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 46 | 47 | $97,055 | $5,210 | 5.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 53 | 67 | $20,100 | $3,853 | 19.2% |
| 91035 | Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | Facility | 2023 | 42 | 42 | $72,660 | $3,098 | 4.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 27 | 28 | $49,980 | $3,070 | 6.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 11 | 11 | $34,595 | $2,725 | 7.9% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 34 | 34 | $23,800 | $1,959 | 8.2% |
| 91040 | Study of esophageal sensation by balloon distension | Facility | 2023 | 32 | 32 | $36,800 | $1,430 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 77 | $29,070 | $8,016 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $24,675 | $6,359 | 25.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 47 | 48 | $99,120 | $5,386 | 5.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 60 | $15,550 | $4,394 | 28.3% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 40 | 40 | $28,000 | $2,347 | 8.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $39,270 | $2,240 | 5.7% |
| 91035 | Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | Facility | 2022 | 31 | 31 | $53,630 | $2,230 | 4.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $6,200 | $2,007 | 32.4% |
| 91040 | Study of esophageal sensation by balloon distension | Facility | 2022 | 25 | 27 | $31,050 | $1,133 | 3.6% |
| 91038 | Prolonged monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2022 | 14 | 14 | $22,400 | $700.59 | 3.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 107 | $36,380 | $12,498 | 34.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 60 | 60 | $31,500 | $9,146 | 29.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 44 | 45 | $92,925 | $5,191 | 5.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 24 | 24 | $15,600 | $4,715 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 55 | $12,650 | $4,473 | 35.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 20 | $9,100 | $3,448 | 37.9% |
About Dr. Philip Katz, MD
Dr. Philip Katz, MD is a Gastroenterology healthcare provider based in Ny, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124097340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Katz, MD has received a total of $28,928 in payments from pharmaceutical and medical device companies, with $1,182 received in 2024. These payments were reported across 37 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($12,588).
As a Medicare-enrolled provider, Katz has provided services to 1,400 Medicare beneficiaries, totaling 1,540 services with total Medicare billing of $148,102. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Ny, NY
- Active Since 03/17/2006
- Last Updated 11/18/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1124097340
Products in Payments
- VOQUEZNA (Drug) $7,000
- LINX (Device) $5,727
- Bravo (Device) $3,045
- FASENRA (Biological) $2,269
- ESOPHYX (Device) $1,692
- Emprint (Device) $1,600
- SUCRAID (Drug) $124.99
- ENDOFLIP (Device) $120.25
- Manometry (Device) $101.29
- Nvision VLE (Device) $63.04
- GENERAL BILIARY DEVICES (Device) $57.03
- BARRX (Device) $55.98
- Beacon (Device) $32.98
- INSPIRA (Device) $31.11
- XELJANZ (Drug) $24.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.